These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6091722)

  • 1. A pilot study of the use of MaxEPA in haemodialysis patients.
    Rylance PB; George MP; Saynor R; Weston MJ
    Br J Clin Pract Suppl; 1984; 31():49-54. PubMed ID: 6091722
    [No Abstract]   [Full Text] [Related]  

  • 2. Fish oil modifies lipids and reduces platelet aggregability in haemodialysis patients.
    Rylance PB; Gordge MP; Saynor R; Parsons V; Weston MJ
    Nephron; 1986; 43(3):196-202. PubMed ID: 3724927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihomo-gamma-linolenic acid in patients with atherosclerosis: effects on platelet aggregation, plasma lipids and low-density lipoprotein-induced inhibition of prostacyclin generation.
    Mikhailidis DP; Barradas MA; Dandona P
    Thromb Haemost; 1985 Dec; 54(4):901-2. PubMed ID: 3911485
    [No Abstract]   [Full Text] [Related]  

  • 4. Dihomo-gamma-linolenic acid in patients with atherosclerosis: effects on platelet aggregation, plasma lipids and low-density lipoprotein-induced inhibition of prostacyclin generation.
    Szczeklik A; Gryglewski RJ; Sladek K; Kostaka-Trabka E; Zmuda A
    Thromb Haemost; 1984 Apr; 51(2):186-8. PubMed ID: 6377563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease of platelet activity after intake of small amounts of eicosapentaenoic acid in diabetics.
    Velardo B; Lagarde M; Guichardant M; Dechavanne M; Beylot M; Sautot G; Berthezene F
    Thromb Haemost; 1982 Dec; 48(3):344. PubMed ID: 6298968
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple sclerosis and MaxEPA.
    Cendrowski W
    Br J Clin Pract; 1986 Sep; 40(9):365-7. PubMed ID: 3542002
    [No Abstract]   [Full Text] [Related]  

  • 7. MaxEPA in multiple sclerosis.
    French JM
    Br J Clin Pract Suppl; 1984; 31():117-21. PubMed ID: 6091716
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of MaxEPA on the serum lipids, platelets, bleeding time and GTN consumption.
    Saynor R; Verel D; Gillott T
    Br J Clin Pract Suppl; 1984; 31():70-4. PubMed ID: 6091723
    [No Abstract]   [Full Text] [Related]  

  • 9. [Polyunsaturated fatty acids in the prevention of arteriosclerosis].
    Sładek K; Dworski R; Nizankowski R; Szczeklik A
    Pol Tyg Lek; 1984 Oct; 39(44):1457-61. PubMed ID: 6096837
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary evaluation of an association of polyunsaturated acids in primary hypertriglyceridemia].
    Marino O; Onofri E
    Clin Ter; 1993 Jul; 143(1):11-4. PubMed ID: 8243016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
    Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
    Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism underlying the inhibition of platelet aggregation by eicosapentaenoic acid and its metabolites.
    Needleman P; Sprecher H; Whitaker MO; Wyche A
    Adv Prostaglandin Thromboxane Res; 1980; 6():61-8. PubMed ID: 6247894
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of dietary fatty acids, prostaglandins and related compounds on the role of platelets in thrombosis.
    Srivastava KC
    Biochem Exp Biol; 1980; 16(3):317-38. PubMed ID: 6268128
    [No Abstract]   [Full Text] [Related]  

  • 14. [Unsaturated fatty acids, eicosanoids and atherosclerosis].
    Schacky CV; Siess W; Lorenz R; Weber PC
    Internist (Berl); 1984 May; 25(5):268-74. PubMed ID: 6376407
    [No Abstract]   [Full Text] [Related]  

  • 15. Eicosapentaenoic acid, bleeding time, and serum lipids.
    Saynor R; Verel D
    Lancet; 1982 Jul; 2(8292):272. PubMed ID: 6124696
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fatty acid and lipid peroxidation in human atherosclerosis].
    Loeper J; Goy J; Emerit J; Rozensztajn L; Jeny C; Bedu O
    Sem Hop; 1983 Jun; 59(22):1657-60. PubMed ID: 6308785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of omega-3 and omega-6 fatty acid-rich oils on the cardiovascular system of thermally injured rabbits: changes in plasma triglycerides, plasma cholesterol, relative blood viscosity, platelet count, and bleeding time.
    Kirmani ZA; Baxter CR; Gorman MA; Ashby J; Ireton-Jones C; Liepa GU
    J Burn Care Rehabil; 1995; 16(3 Pt 1):306-15. PubMed ID: 7673312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hypothesis on the development of acute myocardial infarction in Greenlanders.
    Dyerberg J; Bang HO
    Scand J Clin Lab Invest Suppl; 1982; 161():7-13. PubMed ID: 6293041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients.
    An WS; Kim SE; Kim KH; Lee S; Park Y; Kim HJ; Vaziri ND
    J Ren Nutr; 2009 Jul; 19(4):267-74. PubMed ID: 19539181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherogenic risk in patients undergoing regular dialysis treatment: improvement of lipid pattern and lipoproteins by polyunsaturated omega-3 fatty acids.
    Dionisio P; Caramello E; Bergia R; Valenti M; Cornella C; Pagni R; Bajardi P
    Nephrol Dial Transplant; 1994; 9(4):458. PubMed ID: 8084465
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.